semaglutide prediabetes progression to diabetes step trial Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous 2.4 mg Among Participants With in the Program How Long Has Semaglutide Been

According to data from the 72-week SURMOUNT-1 trial, participants on the maximum dose experienced an average weight loss of 18% of their body weight , with 36.2% achieving a significant reduction in weight[1]

You dont need to do it alone, though

When weight is lost at a faster pace than the skin can naturally retract, the result can be a loss of firmness, particularly in areas like the cheeks, jawline, neck, and around the eyes

[10] The suggestion that it preserves physiological feedback regulation is a reasonable mechanistic concept, but clinical outcome superiority over licensed recombinant human GH (somatropin) has not been established